Profile
IMUX VRTX REGN SGEN ALNY ARGX
Company Name Immunic, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $69.68M $116.96B $58.10B $43.15B $41.50B $33.28B
Employees 0.09K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Daniel Vitt Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
IMUX VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 2
Quant Rating Sell Sell Buy Neutral Strong Sell Sell
Trading
IMUX VRTX REGN SGEN ALNY ARGX
Last Close $0.7272 $459.62 $547.36 $228.74 $331.91 $543.48
High 52 $1.95 $516.74 $1201.76 $228.74 $331.91 $671.75
Low 52 $0.66 $396.64 $482.92 $228.74 $224.58 $435.84
Price vs. 52 Week High -62.71 % -11.05 % -54.45 % 0 % 0 % -19.09 %
Price vs. 52 Week Low 10.18 % 15.88 % 13.34 % 0 % 47.79 % 24.7 %
Total Return
IMUX VRTX REGN SGEN ALNY ARGX
1 Month Return -5.91 % 3.56 % 13.34 % 0 % 7.8 % -6.39 %
3 Month Return -26.91 % -3.16 % -4.55 % 0 % 40.79 % -2.1 %
6 Month Return -33.89 % 12.9 % -23.78 % 0 % 41.67 % -12.52 %
9 Month Return -54.83 % 0.95 % -45.96 % 0 % 23.85 % 2.55 %
YTD Return -27.28 % 14.13 % -23.16 % 0 % 41.05 % -11.63 %
1 Year Return -32.67 % -3.15 % -47.08 % 0 % 32.22 % 24.7 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
IMUX VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -294.9 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
IMUX VRTX REGN SGEN ALNY ARGX
Asset Growth -24.74 % -0.87 % 36.55 %
Gross Profit Growth 100 % 10.25 % 77.08 %
Revenue Growth - 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth -1.29 % -93.69 % 128.87 %
Net Income Growth -7.37 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 74.43 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 77.75 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share 98.75 % 33.84 % 938.02 %
Operating Income Growth 1.18 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -19.68 % -113.93 % 80.31 %
Operating 3 Year CFG 75.95 % -118.65 % 88.36 %
Operating 5 Year CFG 77.11 % -131.3 % -135.21 %
Operating 10 Year CFG 98.77 % 12.43 % -64 %
EPS Growth 52.61 % -114.8 % 369.77 %
EPS Diluted Growth 52.61 % -114.97 % 347.67 %
Book Value Per Share -71.82 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -96.58 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -97.57 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share -99.89 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share -100 % - -
Debt Growth -24.74 % 116.42 % 95.27 %
Free Cash Flow Growth -19.49 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
IMUX VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -469.88 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -326.95 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM 1989.29 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 95.45 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -39320.48 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 0.01 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -0.81 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -0.82 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 14.11 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.34 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -39320.48 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.84 -92.97 19.24 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM -0.89 -119.36 14.77 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM -0.89 -119.36 14.77 -93.1 -914.84 -515.98
Income Statement (TTM)
IMUX VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.1B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.1B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -1 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
IMUX VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.02B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.02B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.04B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
IMUX VRTX REGN SGEN ALNY ARGX
Net Income $-0.1B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.08B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 42.85
AARD Aardvark Therapeutics, Inc. Common Stock 13.92
ABCL AbCellera Biologics Inc. 3.8
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.89
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.16
ABPWW 0.0222
ABSI Absci Corporation 2.77
ABUS Arbutus Biopharma Corporation 3.24
ABVC ABVC BioPharma, Inc. 3.11
ABVX Abivax SA American Depositary Shares 7.96
ACAD ACADIA Pharmaceuticals Inc. 20.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.607
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.18
ACIU AC Immune SA 2.07
ETFs With Exposure to IMUX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 308.03
IBB iShares Biotechnology ETF 0 130
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00004 136.82
BIB ProShares Ultra Nasdaq Biotechnology 0 48.34
VXF Vanguard Extended Market Index Fund 0.00084 197.5
IWC iShares Micro-Cap ETF 0.01842 133.14
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00016 104.8
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.79
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.17
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.16
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.17
IBBQ Invesco Nasdaq Biotechnology ETF 0 21.69
DFAS Dimensional U.S. Small Cap ETF 0.00069355 65.87
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000754 36.52
VTSAX Vanguard Total Stock Market Index Fund 0 150.01
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 6.2925
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00084 149.82
VITSX Vanguard Total Stock Market Index Fund 0 150.04
QQQS Invesco NASDAQ Future Gen 200 ETF 0.359 28.08
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000132752 106.14
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00084 149.83
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 54.025
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0.00084 369.73
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 281.45
Unlock